Will Zevra Therapeutics announce a new clinical trial for Miplyffa by Mar 31, 2025? | Binary | | | 3 months ago | |
What will Zevra Therapeutics' Q4 2024 revenue from Miplyffa sales be? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by 20% or more by end of 2024? | Binary | | | 3 months ago | |
Will Miplyffa's sales reach $50 million by end of Q1 2025? | Binary | | | 3 months ago | |
What will be Zevra Therapeutics' revenue growth rate in 2024? | Categorical | | | 3 months ago | |
Will Zevra's drug Miplyffa reach $100 million in sales by the end of 2025? | Binary | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by more than 50% by the end of 2024? | Binary | | | 3 months ago | |
What will be the revenue generated by Miplyffa for Zevra Therapeutics in the fiscal year 2024? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by 20% or more by Dec 31, 2024? | Binary | | | 3 months ago | |
What will be Zevra Therapeutics' stock price performance by the end of 2024? | Categorical | | | 3 months ago | |
Will Miplyffa generate $100 million or more in sales by the end of 2025? | Binary | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by 20% or more by the end of 2024? | Binary | | | 3 months ago | |
How many countries will approve Miplyffa for Niemann-Pick disease type C treatment by Dec 31, 2024? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics receive a Priority Review Voucher by Dec 31, 2024? | Binary | | | 3 months ago | |
Will Miplyffa be prescribed to more than 500 patients in the US by Dec 31, 2024? | Binary | | | 3 months ago | |
What will be Miplyffa's market share in the Niemann-Pick disease type C treatment market by Dec 31, 2024? | Categorical | | | 3 months ago | |
What will be the performance of Zevra Therapeutics' stock price by end of 2024? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics receive the $150M Priority Review Voucher by end of 2024? | Binary | | | 3 months ago | |
How many prescriptions for Miplyffa will be filled by end of Q1 2025? | Categorical | | | 3 months ago | |
What will be the market share of Miplyffa in the Niemann-Pick disease type C treatment market by the end of 2025? | Categorical | | | 3 months ago | |
Will Miplyffa receive approval from the European Medicines Agency by the end of 2025? | Binary | | | 3 months ago | |
What will be the primary source of Miplyffa's sales revenue by the end of 2025? | Categorical | | | 3 months ago | |
How many patients will be prescribed Miplyffa by the end of 2025? | Categorical | | | 3 months ago | |
What will be the market share of Miplyffa in the Niemann-Pick disease, type C treatment market by Dec 31, 2024? | Categorical | | | 3 months ago | |
How many patients will be treated with Miplyffa by Dec 31, 2024? | Categorical | | | 3 months ago | |
Will the FDA approve another treatment for Niemann-Pick disease, type C by Dec 31, 2024? | Binary | | | 3 months ago | |
Which regulatory body will grant the next major approval for Miplyffa outside of the United States by September 30, 2025? | Categorical | | | 3 months ago | |
How many prescriptions for Miplyffa will be written by the end of Q2 2025? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics announce a partnership or acquisition deal by the end of Q1 2025? | Binary | | | 3 months ago | |
